Total Payments
$10,968
2024 Payments
$1,994
Companies
55
Transactions
435
Medicare Patients
11,063
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$8,541 (77.9%)
Education$1,242 (11.3%)
Consulting$900.00 (8.2%)
Gifts$284.77 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,541 | 410 | 77.9% |
| Education | $1,242 | 22 | 11.3% |
| Consulting Fee | $900.00 | 2 | 8.2% |
| Gift | $284.77 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $2,037 | 83 | $0 (2024) |
| Boston Scientific Corporation | $904.23 | 15 | $0 (2024) |
| Verathon Inc. | $800.00 | 1 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $763.66 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $610.33 | 34 | $0 (2024) |
| PFIZER INC. | $605.83 | 59 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $413.92 | 20 | $0 (2024) |
| COLOPLAST CORP | $375.80 | 11 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $335.64 | 15 | $0 (2024) |
| ABBVIE INC. | $325.81 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,994 | 66 | Dendreon Pharmaceuticals LLC ($399.40) |
| 2023 | $2,256 | 62 | Verathon Inc. ($800.00) |
| 2022 | $1,194 | 52 | Astellas Pharma US Inc ($236.55) |
| 2021 | $738.69 | 32 | Astellas Pharma US Inc ($161.86) |
| 2020 | $355.24 | 13 | Astellas Pharma US Inc ($145.73) |
| 2019 | $1,632 | 94 | Astellas Pharma US Inc ($409.46) |
| 2018 | $1,059 | 55 | Astellas Pharma US Inc ($338.94) |
| 2017 | $1,738 | 61 | BOSTON SCIENTIFIC CORPORATION ($480.17) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $148.66 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $108.94 | General |
| Category: HORMONE THERAPY | ||||||
| 11/20/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $87.62 | General |
| Category: Immunotherapy | ||||||
| 11/06/2024 | ConvaTec Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $43.50 | General |
| Category: CONTINENCE CARE | ||||||
| 11/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: Oncology | ||||||
| 09/30/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/11/2024 | Endo USA, Inc. | AVEED (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/09/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: OS | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: HORMONE THERAPY | ||||||
| 09/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $38.35 | General |
| Category: Diagnostic Imaging | ||||||
| 08/13/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: UROLOGY | ||||||
| 07/16/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diagnostic Imaging | ||||||
| 07/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Oncology | ||||||
| 06/25/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Immunotherapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,642 | 4,020 | $697,515 | $299,047 |
| 2022 | 24 | 2,614 | 4,031 | $639,110 | $279,178 |
| 2021 | 24 | 2,970 | 4,567 | $673,900 | $297,635 |
| 2020 | 20 | 2,837 | 4,526 | $660,065 | $263,163 |
Total Patients
11,063
Total Services
17,144
Medicare Billing
$1.1M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 447 | 877 | $175,400 | $91,081 | 51.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 282 | 411 | $82,225 | $50,173 | 61.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 279 | 409 | $102,250 | $38,466 | 37.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 21 | 180 | $112,500 | $23,220 | 20.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 135 | 168 | $33,600 | $16,554 | 49.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 61 | 69 | $27,255 | $14,934 | 54.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 314 | 479 | $23,950 | $8,561 | 35.7% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $19,740 | $7,508 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $19,950 | $7,503 | 37.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 17 | $15,390 | $5,907 | 38.4% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 118 | 138 | $14,490 | $5,859 | 40.4% |
| 52315 | Complicated removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 11 | 11 | $8,800 | $4,736 | 53.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 20 | 20 | $8,400 | $4,440 | 52.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 313 | 476 | $7,140 | $3,982 | 55.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $9,125 | $3,640 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 41 | $5,535 | $3,076 | 55.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 19 | $4,370 | $2,340 | 53.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 43 | $2,150 | $1,347 | 62.6% |
| 51725 | Simple measurement of pressure of urine flow in bladder | Office | 2023 | 11 | 11 | $4,400 | $1,329 | 30.2% |
| 76870 | Ultrasound scan of scrotum | Office | 2023 | 12 | 14 | $2,030 | $1,290 | 63.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 20 | 21 | $3,675 | $1,124 | 30.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 281 | 379 | $5,685 | $827.57 | 14.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 49 | 50 | $7,500 | $583.74 | 7.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 16 | $800.00 | $325.80 | 40.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 74 | 77 | $1,155 | $239.47 | 20.7% |
About Yi Hsieh
Yi Hsieh is a Urology healthcare provider based in Federal Way, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184628661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yi Hsieh has received a total of $10,968 in payments from pharmaceutical and medical device companies, with $1,994 received in 2024. These payments were reported across 435 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($8,541).
As a Medicare-enrolled provider, Hsieh has provided services to 11,063 Medicare beneficiaries, totaling 17,144 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Federal Way, WA
- Active Since 06/13/2005
- Last Updated 11/28/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1184628661
Products in Payments
- PROVENGE (Drug) $950.60
- NPD Clinical Study (Device) $800.00
- XTANDI (Drug) $687.10
- Xtandi (Drug) $362.29
- TOVIAZ (Drug) $360.76
- Nubeqa (Drug) $339.70
- ORGOVYX (Drug) $294.06
- Rezum (Device) $284.77
- Erleada (Drug) $280.74
- AMS (Device) $267.00
- ERLEADA (Drug) $246.31
- XIAFLEX (Biological) $246.02
- Myrbetriq (Drug) $239.17
- Porges Coloplast (Device) $230.53
- PROLARIS (Device) $224.23
- FIRMAGON (Drug) $195.73
- KEYTRUDA (Biological) $181.55
- CAMCEVI (Drug) $165.90
- ZYTIGA (Drug) $165.12
- JELMYTO (Drug) $155.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.